Where PhDs and companies meet
Menu
Login

Development of photoswitchable MAO-B inhibitors targeting inflammation in osteoarthritis

ABG-137900 Thesis topic
2026-04-08 Public funding alone (i.e. government, region, European, international organization research grant)
Laboratoire CiTCoM UMR 8038 - Université de Paris
Paris - Ile-de-France - France
Development of photoswitchable MAO-B inhibitors targeting inflammation in osteoarthritis
  • Chemistry
  • Biochemistry
photopharmacology, medicinal chemistry; organic chemistry; UV-Vis spectrophotometry, cell culture

Topic description

The ANR project PhotoROS is a multidisciplinary project aimed at developing innovative tools to study and control the activity of monoamine oxidase B (MAO-B), an enzyme involved in oxidative stress and the inflammatory diseases, particularly osteoarthritis. MAO-B generates reactive oxygen species (ROS) in the mitochondria of chondrocytes and synoviocytes, triggering activation of the NLRP3 inflammasome and cartilage degradation. The project aims to develop photoswitchable MAO-B inhibitors whose activity can be reversibly modulated by light (photopharmacology), enabling precise spatiotemporal control of enzymatic activity.

 

The project is structured around six tasks : 1) in silico studies (molecular docking); 2) synthesis of photoswitchable inhibitors ; 3) determination of photophysical and photochemical properties ; 4) in vitro assessment of MAO-B inhibitory activity; 5) cytotoxicity assays and cell culture ; 6) modulation of MAO-B activity in human cells and evaluation of anti-inflammatory properties

Starting date

2026-11-02

Funding category

Public funding alone (i.e. government, region, European, international organization research grant)

Funding further details

ANR

Presentation of host institution and host laboratory

Laboratoire CiTCoM UMR 8038 - Université de Paris

This PhD project will be carried out in collaboration between two research laboratories:

 

CiTCoM UMR CNRS 8038, Inserm U1268, UFR de Pharmacie (Pr. Ludovic Jean, Dr. Lucas Pagès) – Expertise in medicinal chemistry, docking, organic synthesis, and photoswitch compounds

 

INSERM UMR-S 1124 T3S, UFR Sciences Fondamentales et Biomédicales, Université Paris Cité (Pr. Didier Borderie) – Expertise in biochemistry, oxidative stress, and osteoarthritis biology

 

CiTCoM UMR 8038, 4 avenue de l’Observatoire, F-75006 Paris

T3S INSERM UMR-S 1124, 45 rue des Saints Pères F-75006 Paris

PhD title

Doctorat de chimie thérapeutique

Country where you obtained your PhD

France

Institution awarding doctoral degree

Université Paris Cité

Graduate school

Médicament Toxicologie Chimie Imageries

Candidate's profile

We are looking for a candidate with a chemistry-biology background and the following skills :

 

Organic synthesis, purification and characterisation techniques (NMR, MS, HPLC, etc.).

in vitro assays, cell culture (flow cytometry).

Ability to take initiative, propose innovative ideas, and work independently.

Communication skills to present research findings effectively.

2026-07-10
Partager via
Apply
Close

Vous avez déjà un compte ?

Nouvel utilisateur ?